These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Serological diagnosis of hepatitis B using radioimmunological and immunoenzyme technics]. Arndt-Hanser A, Schütt KH. Ric Clin Lab; 1983 Jun 30; 13 Suppl 2():11-8. PubMed ID: 6669872 [No Abstract] [Full Text] [Related]
6. [Circulation of the markers of the hepatitis B virus in different clinical forms of the disease]. Frolov AF, Raksha EA, Nagornova TF, Vasilenko LG. Vrach Delo; 1984 Apr 30; (4):108-11. PubMed ID: 6741040 [No Abstract] [Full Text] [Related]
7. The prevalence of antibodies to hepatitis A and B viruses in Port Chalmers residents. Austin FJ, Maguire T, Jennings LC, MacDiarmid RD. N Z Med J; 1982 Feb 10; 95(701):72-3. PubMed ID: 6281700 [No Abstract] [Full Text] [Related]
8. [Hepatitis B: serological strategy and epidemiological aspects]. Penna R, Rabagliati AM. G Batteriol Virol Immunol; 1981 Feb 10; 74(1-6):145-62. PubMed ID: 7030851 [No Abstract] [Full Text] [Related]
9. [Serologic markers of hepatitis B virus. Recent progress]. Mora Pérez I, Porres Cubero JC, Carreño García V. Rev Clin Esp; 1984 Apr 15; 173(1):9-14. PubMed ID: 6330799 [No Abstract] [Full Text] [Related]
10. Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination. Papaevangelou V, Hadjichristodoulou C, Cassimos DC, Pantelaki K, Tzivaras A, Hatzimichael A, Theodoridou M. Infection; 2008 Mar 15; 36(2):135-9. PubMed ID: 18231718 [Abstract] [Full Text] [Related]
11. [Prevalence of hepatitis B in a dermatological hospital]. Catania G, Collina D, Di Ciommo V, Rubino S. Ann Ig; 1995 Mar 15; 7(2):115-9. PubMed ID: 8814660 [No Abstract] [Full Text] [Related]
12. What you need to know: interpreting hepatitis B viral markers. Tan CK. Singapore Med J; 1998 Mar 15; 39(3):139-40. PubMed ID: 9632977 [No Abstract] [Full Text] [Related]
13. [Serological markers correlated with hepatitis B virus. Study made predominantly in chronic hepatitis in children]. Calzia R, Ciravegna B, Navone C, Fiorini R, Tolentino P. Minerva Pediatr; 1981 Aug 31; 33(16):805-15. PubMed ID: 6273707 [No Abstract] [Full Text] [Related]
16. [Prevalence of viral hepatitis B markers in the region of Tataouine (southern Tunisia)]. Gorgi Y, Ayed K, Jenhani F, Pichoud C, Trepo C. Arch Inst Pasteur Tunis; 1989 Aug 31; 66(3-4):251-61. PubMed ID: 2488540 [Abstract] [Full Text] [Related]
18. [Favorable outcome in chronic active hepatitis caused by B virus in childhood]. Cadrobbi P, Bortolotti F, Crivellaro C, Rugge M, Armigliato M, Realdi G, Bertaggia A. Minerva Pediatr; 1984 Jul 31; 36(13-14):685-9. PubMed ID: 6503897 [No Abstract] [Full Text] [Related]
19. [Features of verification of virus B hepatitis in patients with acute cholecystitis]. Borisov AE, Alidzhanova SSh, Veselov IuE. Vestn Khir Im I I Grek; 2010 Jul 31; 169(2):20-4. PubMed ID: 20552784 [Abstract] [Full Text] [Related]
20. Prevalence of hepatitis B markers in Indochinese refugees. Chaudhary RK, Nicholls ES, Kennedy DA. Can Med Assoc J; 1981 Dec 01; 125(11):1243-6. PubMed ID: 7332883 [Abstract] [Full Text] [Related] Page: [Next] [New Search]